DOKIXSKMTRYSGZ-RDFOUATCSA-N
C35H41F2N7O5 — CID 138576577
Data last refreshed: (MolForge compound catalog, from PubChem)
About DOKIXSKMTRYSGZ-RDFOUATCSA-N
DOKIXSKMTRYSGZ-RDFOUATCSA-N (PubChem CID 138576577) has the molecular formula C35H41F2N7O5 and a molecular weight of 677.75 g/mol. Its IUPAC name is 2-[3,3-difluoro-1-[(2S)-2-hydroxy-3-methylbutanoyl]piperidin-4-yl]oxy-5-[2-[[6-methoxy-5-[1-(oxetan-3-yl)piperidin-4-yl]-2-pyridinyl]amino]pyrimidin-4-yl]benzonitrile.
Molecular Properties
| Compound Name | DOKIXSKMTRYSGZ-RDFOUATCSA-N |
|---|---|
| PubChem CID | 138576577 |
| Molecular Formula | C35H41F2N7O5 |
| Molecular Weight | 677.75 g/mol |
| Exact Mass | 677.31 |
| IUPAC Name | 2-[3,3-difluoro-1-[(2S)-2-hydroxy-3-methylbutanoyl]piperidin-4-yl]oxy-5-[2-[[6-methoxy-5-[1-(oxetan-3-yl)piperidin-4-yl]-2-pyridinyl]amino]pyrimidin-4-yl]benzonitrile |
| SMILES | COc1nc(Nc2nccc(-c3ccc(OC4CCN(C(=O)[C@@H](O)C(C)C)CC4(F)F)c(C#N)c3)n2)ccc1C1CCN(C2COC2)CC1 |
| InChI | InChI=1S/C35H41F2N7O5/c1-21(2)31(45)33(46)44-15-11-29(35(36,37)20-44)49-28-6-4-23(16-24(28)17-38)27-8-12-39-34(40-27)42-30-7-5-26(32(41-30)47-3)22-9-13-43(14-10-22)25-18-48-19-25/h4-8,12,16,21-22,25,29,31,45H,9-11,13-15,18-20H2,1-3H3,(H,39,40,41,42)/t29?,31-/m0/s1 |
| InChIKey | DOKIXSKMTRYSGZ-RDFOUATCSA-N |
| XLogP | 4.37 |
| TPSA | 145.96 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 677.75 |
| LogP ≤ 5 | 4.37 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138576577 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.